The Commission published yesterday guidance to ensure that clinical trials can continue taking place in the EU during the COVID-19 pandemic. Aim The aim is to mitigate the disruption of clinical research in Europe and therefore the negative effects of the pandemic, without compromising on quality and safety. These recommendations are an important part of the […]
Read More
New project to improve biological detection, identification & monitoring equipment
A new phase in EDA’s testing and evaluation project of biological detection, identification and monitoring (DIM) equipment was launched on 26 February at a kick-off meeting at the Agency. Aims Dubbed ‘T&E Bio DIM Phase 2’ (2020-2023) the project aims to deliver improved testing and evaluation capabilities to ensure the performance of biological DIM systems […]
Read More